Long-term Control in Rhinosinusitis After Functional Endoscopic Sinus Surgery (FESS)

Universitaire Ziekenhuizen KU Leuven389 enrolled

Overview

State-of-the-art documents like ARIA and european position paper on rhinosinusitis (EPOS) provide clinicians with evidence-based treatment algorithms for allergic rhinitis (AR) and chronic rhinosinusitis (CRS) respectively (1)(2) . The currently available medications can alleviate symptoms associated with AR and RS, and most patients with RS benefit from endoscopic sinus surgery (ESS). In real life, a significant percentage of patients with AR and CRS continue to experience bothersome symptoms despite adequate treatment. This group with so-called severe chronic upper airway disease (SCUAD) represents a therapeutic challenge (3).

Study Type

OBSERVATIONAL

Enrollment

389

Conditions

Condition of Patient 3 Years After FESS-operation

Eligibility

Sex: ALLMin age: 19 YearsMax age: 74 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patients that have undergone bilateral ESS for inflammatory sinonasal disease, without additional sino-nasal surgery after the ESS. 2. Age \> 18 and \< 75 years. 3. Written informed consent 4. Dutch, French or English speaking patients Exclusion Criteria: 1. Unilateral ESS 2. Benign and malignant tumor disease 3. Patient with a psychiatric, addictive, or any disorder of which the investigators feel at the time of evaluation for participation in the study that this may compromise the ability to give truly informed consent for participation in this study or provide reliable information on the questionnaire 4. Lack of knowledge of Dutch, French or English

Locations (2)

Outcomes

Primary Outcomes

Control Status of Patients With Rhinosinusitis

1\. Percentage of patients with rhinosinusitis that are fully controlled, partly controlled and uncontrolled according to the new european position paper on rhinosinusitis (EPOS) definitions at a mean interval of 3 years after endoscopic sinus surgery.

Time frame: 3 years after FESS

Secondary Outcomes

Control Nasal Endoscopy

Evaluating of difference in control if nasal endoscopy is performed three years after ESS.

Time frame: 3 years after ESS